SCHEMBL23919660

SCHEMBL23919660

CC(c1ccc(O)cc1)(c1ccc(O)cc1)c1ccc(C(C)(c2cc(Cc3ccc(O)cc3)c(O)c(Cc3ccc(O)cc3)c2)c2cc(Cc3ccc(O)cc3)c(O)c(Cc3ccc(O)cc3)c2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
ESR1 P03372 10/20 0.48
ESR2 Q92731 9/20 0.48
KEAP1 Q14145 1/20 0.42
LMNA P02545 1/20 0.41
TYR P14679 1/20 0.41
CYP3A4 P08684 1/20 0.41
AR P10275 1/20 0.41
HPGD P15428 1/20 0.41
TSHR P16473 1/20 0.41
SLC6A2 P23975 1/20 0.41
SLC6A4 P31645 1/20 0.41
HTR6 P50406 1/20 0.41
ESRRG P62508 1/20 0.41
SLC6A3 Q01959 1/20 0.41
HSD17B10 Q99714 1/20 0.41
SHBG P04278 1/20 0.39
MAPT P10636 1/20 0.38
HSPA5 P11021 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10446216 1.00 MEN1 (0.53) MEN1KMT2AESR1ESR2KEAP1
SCHEMBL10445776 0.94 ESR1 (0.48) MEN1KMT2AESR1ESR2KEAP1
SCHEMBL14666793 0.94 ESR1 (0.61) MEN1KMT2AESR1ESR2KEAP1
SCHEMBL20905242 0.89 ESR1 (0.43) MEN1KMT2AESR1ESR2KEAP1
SCHEMBL19495119 0.86 MEN1 (0.41) MEN1KMT2AESR1ESR2KEAP1
SCHEMBL25998593 0.86 MEN1 (0.41) MEN1KMT2AESR1ESR2KEAP1
SCHEMBL4057123 0.86 CYP2C19 (0.50) MEN1KMT2AESR1ESR2KEAP1
SCHEMBL4058701 0.86 ALOX15 (0.50) MEN1KMT2AESR1ESR2KEAP1
SCHEMBL21232493 0.85 MEN1 (0.40) MEN1KMT2AESR1ESR2KEAP1
SCHEMBL13416448 0.84 ESR1 (0.45) MEN1KMT2AESR1ESR2KEAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11572442-B2 Compound, polyimide resin and method of producing the same, photosensitive resin composition, patterning method and method of forming cured film, interlayer insulating film, surface protective film, and electronic component INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2023-02-07 US disclosed
US-20210317270-A1 NOVEL COMPOUND, POLYIMIDE RESIN AND METHOD OF PRODUCING THE SAME, PHOTOSENSITIVE RESIN COMPOSITION, PATTERNING METHOD AND METHOD OF FORMING CURED FILM, INTERLAYER INSULATING FILM, SURFACE PROTECTIVE FILM, AND ELECTRONIC COMPONENT SHIN-ETSU CHEMICAL CO., LTD. (JP) 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11572442-B2 Compound, polyimide resin and method of producing the same, photosensitive resin composition, patterning method and method of forming cured film, interlayer insulating film, surface protective film, and electronic component BRIX1, RBX1, HAX1 MEN1 2726/4885KMT2A 1125/4885ESR1 54/4885
US-20210317270-A1 NOVEL COMPOUND, POLYIMIDE RESIN AND METHOD OF PRODUCING THE SAME, PHOTOSENSITIVE RESIN COMPOSITION, PATTERNING METHOD AND METHOD OF FORMING CURED FILM, INTERLAYER INSULATING FILM, SURFACE PROTECTIVE FILM, AND ELECTRONIC COMPONENT BRIX1, HAX1, RBX1 MEN1 2997/4885KMT2A 1400/4885ESR1 54/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.